Fatema Abdurrob

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The dismal success rate of clinical trials for Alzheimer's disease (AD) motivates us to develop model systems of AD pathology that have higher predictive validity. The advent of induced pluripotent stem cells (iPSCs) allows us to model pathology and study disease mechanisms directly in human neural cells from healthy individual as well as AD patients.(More)
  • 1